IJPR  articles are Indexed in SCOPUS (2010 - 2021)Click Here     *Five Years Citation in Google scholar (2016 - 2020) is. 1451*        Now IJPR is Q2 in SJR Ranking     Scopus Coverage of IJPR (2010-2021 Issue 1)            

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Depression And Anxiety In Cardiovascular Diseases: Emerging Role Of Psychotherapy

Author: , RAJA D, ELMUTAZ BELAH MOHAMMED, MANJU ROSY JOSE, LIZ MATHEW, JAYAKUMAR C, ANAND VIJAYAKUMAR P R
Abstract: Psychotherapy, traditionally known as ‘talking cure’ is a vital and emerging intervention that uses various techniques to reduce psychological symptoms. These symptoms can cause impaired physical, physiological, cognitive, and social functioning which in-turn leads to major adverse cardiac events. The Cardiovascular diseases (CVDs) account for about 31% of deaths globally and psychological illnesses such as depression and anxiety associated with CVDs pose a major threat to the world. Psychotherapy has proven its efficacy in helping patients change their self-destructive or unhealthy behaviors originating from negative thoughts about the disease. This review discusses the bidirectional relationship between depression and anxiety with CVDs, in addition to the role of psychotherapy in reducing depression and anxiety associated with CVDs such as Heart Failure (HF), Atrial Fibrillation (AFib) and Coronory Artery Disease (CAD) outcomes. Unrecognized, untreated depression and anxiety in cardiovascular diseases results in worsening of cardiac function and quality of life. There are also many challenges associated with antidepressants and anti-anxiety drugs in cardiovascular diseases. Therefore, appropriate screening and implementing psychological intervention helps to identify patients at risk and enhance cardiac outcomes and quality of life with limited cardiovascular side effects. However, collaborative cardiological and psychological studies are needed for providing individualized psychotherapy for CVDs patients.
Keyword: Psychotherapy, Cardiovascular diseases, Depression, Anxiety, Cardiovascular disease
DOI: https://doi.org/10.31838/ijpr/2021.13.01.064
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free